Skip to main content

The Delhi High Court Passes an ex parte order injuncting the Defendants from using the mark TATA in any manner

In the Tata Sons Ltd. v. Amar Singh Gupta and Ajay Gupta case, the Defendants were dealing in PVC flexible pipes bearing the mark B TATA ®. After hearing the arguments made by Anand and Anand, the Hon’ble Judge passed an ex parte order injuncting the Defendants from using the mark TATA in any manner whatsoever.

The Hon’ble Judge further appointed a Local Commissioner to visit the premises of the Defendants to seize and seal all infringing goods that may be found in their power and possession. The Local Commissioner has also been empowered to ask the Defendants to disclose the name of the manufacturer/source of the infringing goods so that such goods can also be seized and the infringement can be nipped in the bud.

Read more: https://www.anandandanand.com/?s=TATA

 

Most Recent

News & Insights

VIEW ALL
News & Updates, Thought Leadership
•
Nov 07, 2026

Pharmaceutical innovation and access to medicines are closely connected aspects of public health. While patent protection can encourage investment in research

Can Public Health Override a Pharmaceutical Patent? The BPaL Patent Dispute in India
News & Updates, Thought Leadership
•
Nov 04, 2026

Imagine discovering an Instagram account using your company’s name, a website offering products under a deceptively similar identity, or an AI-generated

Can AI Steal Your Brand Identity? Trademark Squatting and AI Misuse in India
News & Updates, Thought Leadership
•
Nov 02, 2026

First published by AsiaIP. Author: Lakshmidevi Somanath Copyright law has traditionally addressed the asymmetry between the costs of creating a work and

What is Copyright Worth When Machines Do the Creating? Lessons from Streaming and Gaming
News & Updates, Thought Leadership
•
Oct 31, 2026

A startup has developed a new technology, filed a patent application and begun building its product. The filing is an important milestone. But what happens

Your Startup Has Filed a Patent. Now What? The Commercial Value of IP